A method to improve the efficacy of topical eflornithine hydrochloride cream

References

• Azziz R. (2003). The evaluation and management of hirsutism. Obstet Gynecol 101(Pt 1):995–1007
   PubMed Web of Science ®Google Scholar
• Badran MM, Kuntsche J, Fahr A. (2009). Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 36:511–23
   PubMed Web of Science ®Google Scholar
• Balfour JA, McClellan K. (2001). Topical eflornithine. Am J Clin Dermatol 2:197–201
   PubMedGoogle Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. (2012). Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 64:11–29
   PubMed Web of Science ®Google Scholar
• Burri C, Brun R. (2003). Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 90(Supp 1):S49–52
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Cancelo MJ. (2010). Comprehensive clinical management of hirsutism. Gynecol Endocrinol 26:484–93
   PubMed Web of Science ®Google Scholar
• Chappuis F, Udayraj N, Stietenroth K, et al. (2005). Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clin Infect Dis 41:748–51
   PubMed Web of Science ®Google Scholar
• Dennerlein K, Schneider D, Goen T, et al. (2013). Studies on percutaneous penetration of chemicals – impact of storage conditions for excised human skin. Toxicol In Vitro 27:708–13
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF. (2010). Diagnosis and management of hirsutism. Ann N Y Acad Sci 1205:166–74
   PubMed Web of Science ®Google Scholar
• Falsetti L, Gambera A, Platto C, Legrenzi L. (2000). Management of hirsutism. Am J Clin Dermatol 1:89–99
   PubMedGoogle Scholar
• Hamzavi I, Tan E, Shapiro J, Lui H. (2007). A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 57:54–9
   PubMed Web of Science ®Google Scholar
• Harrison S, Somani N, Bergfeld WF. (2010). Update on the management of hirsutism. Cleve Clin J Med 77:388–98
   PubMed Web of Science ®Google Scholar
• Hickman JG, Huber F, Palmisano M. (2001). Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair. Curr Med Res Opin 16:235–44
   PubMed Web of Science ®Google Scholar
• Jackson J, Caro JJ, Caro G, et al. (2007). The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism. Int J Dermatol 46:976–81
   PubMed Web of Science ®Google Scholar
• Jo SJ, Choi SJ, Yoon SY, et al. (2013). Valproic acid promotes human hair growth in in vitro culture model. J Dermatol Sci 72:16–24
   PubMed Web of Science ®Google Scholar
• Jobanputra KS, Rajpal AV, Nagpur NG. (2007). Eflornithine. Indian J Dermatol Venereol Leprol 73:365–6
   PubMed Web of Science ®Google Scholar
• Kang JI, Kim EJ, Kim MK, et al. (2013). The promoting effect of Ishige sinicola on hair growth. Mar Drugs 11:1783–99
   PubMed Web of Science ®Google Scholar
• Kaushik S, Hord AH, Denson DD, et al. (2001). Lack of pain associated with microfabricated microneedles. Anesth Analg 92:502–4
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. (2012). Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547–68
   PubMed Web of Science ®Google Scholar
• Koulouri O, Conway GS. (2009). Management of hirsutism. BMJ 338:823–6
   Web of Science ®Google Scholar
• Kumar A, Li X, Sandoval MA, et al. (2011). Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomed 6:1253–64
   PubMed Web of Science ®Google Scholar
• Kumar A, Wonganan P, Sandoval MA, et al. (2012). Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release 163:230–9
   PubMed Web of Science ®Google Scholar
• Malhotra B, Noveck R, Behr D, Palmisano M. (2001). Percutaneous absorption and pharmacokinetics of eflornithine HCl 13.9% cream in women with unwanted facial hair. J Clin Pharmacol 41:972–8
   PubMed Web of Science ®Google Scholar
• Milford E, Pepin J. (1992). Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping. Lancet 340:652–655
   PubMed Web of Science ®Google Scholar
• Mofid A, Seyyed Alinaghi SA, Zandieh S, Yazdani T. (2008). Hirsutism. Int J Clin Pract 62:433–43
   PubMed Web of Science ®Google Scholar
• Mpia B, Pepin J. (2002). Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis. Trop Med Int Health 7:775–9
   PubMed Web of Science ®Google Scholar
• Naguib YW, Kumar A, Cui Z. (2014). The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil. Acta Pharm Sin B 4:94–9
   PubMed Web of Science ®Google Scholar
• Onselen JV. (2011). Hirsutism: causes and treatment for women. Br J Nurs 20:985–6,988,990
   PubMedGoogle Scholar
• Park JH, Choi SO, Seo S, et al. (2010). A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm 76:282–9
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581–7
   PubMed Web of Science ®Google Scholar
• Priotto G, Pinoges L, Fursa IB, et al. (2008). Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. BMJ 336:705–8
   PubMed Web of Science ®Google Scholar
• Rittmaster RS. (1997). Hirsutism. Lancet 349:191–5
   PubMed Web of Science ®Google Scholar
• Saravanan C, Kumudhavalli MV, Kumar M, Jayakar B. (2009). A new validated RP-HPLC method for estimation of eflornithine hydrochloride in tablet dosage form. J Pharm Res 2:1730–1
   Google Scholar
• Shapiro J, Lui H. (2005). Treatments for unwanted facial hair. Skin Ther Lett 10:1–4
   PubMedGoogle Scholar
• Shapiro J, Lui H. (2001). Vaniqa – eflornithine 13.9% cream. Skin Ther Lett 6:1–3, 5
   PubMedGoogle Scholar
• Slominski A, Paus R, Costantino R. (1991). Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol 96:172–9
   PubMed Web of Science ®Google Scholar
• Sornalingam S, Cooper M. (2014). Hirsutism. InnovAiT Educ Inspir Gen Pract 7:160–7
   Google Scholar
• Stahl J, Wohlert M, Kietzmann M. (2012). Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points. BMC Pharmacol Toxicol 13:5
   PubMed Web of Science ®Google Scholar
• Stenn KS, Paus R. (2001). Controls of hair follicle cycling. Physiol Rev 81:449–94
   PubMed Web of Science ®Google Scholar
• Wolf JE Jr, Shander D, Huber F, et al. (2007). Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 46:94–8
   PubMed Web of Science ®Google Scholar
• Xiao G, Li X, Kumar A, Cui Z. (2012). Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responses. Eur J Pharm Biopharm 82:212–17
   PubMed Web of Science ®Google Scholar